Index A

Abciximab: Sec. 3 Ch. 49 [sidebar]

in coronary artery disease: Sec. 3, Ch. 45

Abdominal pain

in peripheral arterial disease: Sec. 3, Ch. 44

Abdominal aortic aneurysm: Sec. 3, Ch. 44

Abuse

elder: Sec. 4, Ch. 64

Acarbose: Sec. 3, Ch. 34

Acebutolol

in abnormal heart rhythms: Sec. 3, Ch. 47

in coronary artery disease: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46

in high blood pressure: Sec. 3, Ch. 43

Acetaminophen

alcohol interactions with: Sec. 3 Ch. 32 [sidebar]

for pain: Sec. 3, Ch. 24

side effects of: Sec. 3, Ch. 24

Acetyl-L carnitine: Sec. 2, Ch. 7

Acetylcholine: Sec. 2, Ch. 6

in Alzheimer's disease: Sec. 3, Ch. 27

in delirium: Sec. 3 Ch. 26 [detail]

in dementia: Sec. 3, Ch. 27

Achalasia: Sec. 3, Ch. 54; Sec. 3, Ch. 54

Achilles bursitis: Sec. 3, Ch. 40

Achilles tendinitis: Sec. 3, Ch. 40

Acid reflux: Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54

Acne rosacea: Sec. 3, Ch. 35; Sec. 3, Ch. 35

Acrochordon: Sec. 3 Ch. 35 [sidebar]

Actinic keratosis: Sec. 3, Ch. 51

Action tremor: Sec. 3, Ch. 30

Activated protein C resistance: Sec. 3, Ch. 49

Activities of daily living: Sec. 1, Ch. 3

assistive devices for: Sec. 2, Ch. 13; Sec. 2, Ch. 13

in dementia: Sec. 3, Ch. 27

Acupuncture: Sec. 3, Ch. 24; Sec. 2, Ch. 7

in rehabilitation: Sec. 2, Ch. 13

Adalimumab: Sec. 3, Ch. 41

Adenosine: Sec. 3, Ch. 47

Adjuvant therapy

in cancer: Sec. 3, Ch. 50

Adsorbents

in diarrhea: Sec. 3, Ch. 55

Adult day care: Sec. 2, Ch. 15

Adult Protective Services: Sec. 4, Ch. 64

Advance directive: Sec. 2, Ch. 16; Sec. 4, Ch. 65

in cancer: Sec. 3, Ch. 50

in COPD: Sec. 3, Ch. 53

in heart failure: Sec. 3, Ch. 46

in Parkinson's disease: Sec. 3, Ch. 30

in progressive supranuclear palsy: Sec. 3, Ch. 30

Advanced sleep phase syndrome: Sec. 3, Ch. 31

Aerobic exercise: Sec. 2, Ch. 13; Sec. 3, Ch. 60

in arthritis: Sec. 3, Ch. 60

in coronary artery disease: Sec. 3, Ch. 60

after stroke: Sec. 3, Ch. 60

Age spots: Sec. 3 Ch. 35 [sidebar]

Aging: Sec. 1

of arteries: Sec. 1, Ch. 2

body water changes with: Sec. 3, Ch. 18

demographics of: Sec. 1, Ch. 3; Sec. 1, Ch. 3

driving skill changes with: Sec. 4, Ch. 62

function decline with: Sec. 1, Ch. 1

healthy: Sec. 1, Ch. 1; Sec. 1, Ch. 1

information resources on: 881-882

intimacy and: Sec. 4, Ch. 63

of bladder: Sec. 1, Ch. 2; Sec. 3, Ch. 57

of bones: Sec. 1, Ch. 2

of brain: Sec. 1, Ch. 2

of breasts: Sec. 1, Ch. 2

of cartilage: Sec. 1, Ch. 2

of cells: Sec. 1, Ch. 1

of digestive system: Sec. 1, Ch. 2

of ears: Sec. 1, Ch. 2

of endocrine system: Sec. 1, Ch. 2

of eyes: Sec. 1, Ch. 2

of female genitals: Sec. 3, Ch. 58

of heart: Sec. 1, Ch. 2; Sec. 1, Ch. 2

of immune system: Sec. 1, Ch. 2

of joints: Sec. 1, Ch. 2

of kidneys: Sec. 1, Ch. 2

of liver: Sec. 1, Ch. 2

of lungs: Sec. 1, Ch. 2

of mouth: Sec. 1, Ch. 2

of muscles: Sec. 1, Ch. 2

of nervous system: Sec. 1, Ch. 2

of nose: Sec. 1, Ch. 2

of organs: Sec. 1, Ch. 1; Sec. 1, Ch. 2

of ovaries: Sec. 1, Ch. 2

of reproductive organs: Sec. 1, Ch. 2

of skin: Sec. 1, Ch. 2; Sec. 3, Ch. 35

of testes: Sec. 1, Ch. 2

of urethra: Sec. 3, Ch. 57

of urinary tract: Sec. 1, Ch. 2

of voice: Sec. 3, Ch. 38

self-image changes with: Sec. 4, Ch. 63

sexual changes with: Sec. 3, Ch. 58; Sec. 3, Ch. 58

sleep pattern changes with: Sec. 3, Ch. 31

social changes with: Sec. 4, Ch. 61

temperature control and: Sec. 3, Ch. 19; Sec. 3, Ch. 19

worldwide: Sec. 1, Ch. 3

AIDS: (see HIV infection)

Air-conditioning: Sec. 3, Ch. 19

Air-fluidized bed: Sec. 3, Ch. 35

Airways

defense mechanisms of: Sec. 3, Ch. 52

obstruction of: Sec. 3, Ch. 53

after surgery: Sec. 2, Ch. 12

Akathisia: Sec. 3, Ch. 30

Albumin

in undernutrition: Sec. 3, Ch. 17

Albuterol: Sec. 3, Ch. 53

Alcohol use and abuse: Sec. 3 Ch. 32 [sidebar]

drug interactions with: Sec. 3 Ch. 32 [sidebar]

hypothermia and: Sec. 3, Ch. 19

acid reflux and: Sec. 3, Ch. 54

arrhythmias with: Sec. 3, Ch. 47

delirium with: Sec. 3, Ch. 26

dementia with: Sec. 3 Ch. 27 [sidebar]

erectile dysfunction with: Sec. 3 Ch. 59 [detail]

gout and: Sec. 3, Ch. 41

high blood pressure and: Sec. 3, Ch. 43

information resources on: 882

mouth cancer and: Sec. 3, Ch. 51

osteoporosis and: Sec. 3, Ch. 22

platelet count and: Sec. 3, Ch. 49

undernutrition and: Sec. 3 Ch. 17 [detail]; Sec. 3, Ch. 17

urinary incontinence with: Sec. 3, Ch. 57

Alcoholism: Sec. 3 Ch. 32 [sidebar]

Aldosterone antagonists: Sec. 3, Ch. 46; Sec. 3, Ch. 46

Aldosterone

aging-related changes in: Sec. 1, Ch. 2

Alendronate: Sec. 3, Ch. 22

Allergist: Sec. 2, Ch. 9

Allergy and allergic reactions

to chamomile: Sec. 2, Ch. 7

to chondroitin: Sec. 2, Ch. 7

to echinacea: Sec. 2, Ch. 7

to glucosamine: Sec. 2, Ch. 7

to influenza vaccine: Sec. 3, Ch. 52

rhinitis: Sec. 3, Ch. 38

sinusitis: Sec. 3, Ch. 38; Sec. 3, Ch. 38

Allergy shots: Sec. 3, Ch. 38

Allicin: Sec. 2, Ch. 7

Allopurinol

in gout: Sec. 3, Ch. 41; Sec. 3, Ch. 41

in multiple myeloma: Sec. 3, Ch. 51

Alpha agonists

urinary incontinence with: Sec. 3, Ch. 57

Alpha reductase blockers: Sec. 3, Ch. 59

Alpha-beta-blockers: Sec. 3, Ch. 43; Sec. 3, Ch. 43

Alpha-blockers

in benign prostatic hyperplasia: Sec. 3, Ch. 59

fainting with: Sec. 3, Ch. 20

in high blood pressure: Sec. 3, Ch. 43; Sec. 3, Ch. 43

in prostatitis: Sec. 3, Ch. 59

urinary incontinence with: Sec. 3, Ch. 57

Alprostadil: Sec. 3, Ch. 59

Alteplase

in coronary artery disease: Sec. 3, Ch. 45

in stroke: Sec. 3, Ch. 28

Alternative medicine: Sec. 2, Ch. 7

in cancer: Sec. 3, Ch. 50

safety of: Sec. 2, Ch. 7

Alzheimer's disease: Sec. 3, Ch. 27

acetyl-L carnitine in: Sec. 2, Ch. 7

amyloid angiopathy in: Sec. 3 Ch. 28 [detail]

driving and: Sec. 4, Ch. 62

ginkgo biloba in: Sec. 2, Ch. 7

information resources on: 882

intimacy and: Sec. 4, Ch. 63

Amantadine

in influenza: Sec. 3, Ch. 52; Sec. 3, Ch. 52

in Parkinson's disease: Sec. 3, Ch. 30; Sec. 3, Ch. 30

Amaurosis fugax: Sec. 3, Ch. 36

American Board of Specialties: Sec. 2, Ch. 8

American Medical Association: Sec. 2, Ch. 8

Amiloride: Sec. 3, Ch. 18

Amiodarone

in abnormal heart rhythms: Sec. 3, Ch. 47

in atrial flutter and fibrillation: Sec. 3, Ch. 47

hyperthyroidism with: Sec. 3, Ch. 33

hypothyroidism with: Sec. 3, Ch. 33; Sec. 3, Ch. 33

in ventricular tachycardia: Sec. 3, Ch. 47

Amitriptyline

in depression: Sec. 2, Ch. 6; Sec. 3, Ch. 32

urinary incontinence with: Sec. 3, Ch. 57

Amlodipine

in coronary artery disease: Sec. 3, Ch. 45

in high blood pressure: Sec. 3, Ch. 43

Amputation

information resources on: 882

leg: Sec. 2, Ch. 13

Amyloid angiopathy: Sec. 3 Ch. 28 [detail]

Amyloid plaques: Sec. 3, Ch. 27

Amyloidosis: Sec. 3 Ch. 29 [sidebar]

in multiple myeloma: Sec. 3, Ch. 51

Amyotrophic lateral sclerosis

swallowing difficulty in: Sec. 3, Ch. 54

Anabolic steroids

medicinal herb interactions with: Sec. 2, Ch. 7

Anagrelide

in polycythemia: Sec. 3, Ch. 49

in thrombocythemia: Sec. 3, Ch. 49

Anakinra: Sec. 3, Ch. 41

Analgesics: Sec. 3, Ch. 24

in cancer: Sec. 3, Ch. 50

during rehabilitation: Sec. 2, Ch. 13

opioid: (see Opioids)

in prostatitis: Sec. 3, Ch. 59

in postsurgical pain: Sec. 2, Ch. 12

in terminal illness: Sec. 2, Ch. 16

     in terminal illness: Sec. 2, Ch. 16

Anastrozole: Sec. 3, Ch. 51

Androgens: (see also Testosterone)

in myelofibrosis: Sec. 3, Ch. 49

Anemia: Sec. 3, Ch. 49

aplastic: Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]

in bleeding: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49

causes of: Sec. 3, Ch. 49

of chronic disease: Sec. 3, Ch. 49; Sec. 3, Ch. 49

in chronic lymphocytic leukemia: Sec. 3, Ch. 51

dizziness with: Sec. 3, Ch. 20

fainting with: Sec. 3, Ch. 20; Sec. 3, Ch. 20

in folic acid deficiency: Sec. 3, Ch. 49; Sec. 3, Ch. 49

hemolytic: Sec. 3, Ch. 49

iron deficiency: Sec. 3, Ch. 49; Sec. 3, Ch. 49

in multiple myeloma: Sec. 3, Ch. 51; Sec. 3, Ch. 51

in myelofibrosis: Sec. 3, Ch. 49

pernicious: Sec. 3, Ch. 49

in rheumatoid arthritis: Sec. 3, Ch. 41

in vitamin B₁₂ deficiency: Sec. 3, Ch. 49; Sec. 3, Ch. 49; Sec. 3, Ch. 49

Anesthesia: Sec. 2, Ch. 12

Anesthesiologist: Sec. 2, Ch. 9

Aneurysm: Sec. 3, Ch. 44

brain: Sec. 3 Ch. 28 [detail]

rupture of: Sec. 3, Ch. 44; Sec. 3, Ch. 44

surgical risk and: Sec. 2, Ch. 12

in temporal arteritis: Sec. 3, Ch. 42; Sec. 3, Ch. 42; Sec. 3, Ch. 42

Angina: Sec. 3, Ch. 44; Sec. 3, Ch. 45; Sec. 3, Ch. 45

emergency treatment of: Sec. 3, Ch. 45

Angiography

in aortic aneurysm: Sec. 3, Ch. 44

in aortic dissection: Sec. 3, Ch. 44

cardiac: Sec. 2, Ch. 10; Sec. 2, Ch. 10

in clotting disorders: Sec. 3, Ch. 49

in coronary artery disease: Sec. 3, Ch. 45

fluorescein: Sec. 3, Ch. 36; Sec. 3, Ch. 36; Sec. 3, Ch. 36

peripheral artery: Sec. 3, Ch. 44

pulmonary artery: Sec. 3, Ch. 44

in stroke: Sec. 3, Ch. 28

Angioma: Sec. 3 Ch. 35 [sidebar]

Angioplasty

carotid: Sec. 3, Ch. 28

coronary

     exercise after: Sec. 3, Ch. 60

     in heart attack: Sec. 3, Ch. 45

Angiotensin II receptor blockers

in coronary artery disease: Sec. 3, Ch. 45

in diabetes: Sec. 3, Ch. 34

in heart failure: Sec. 3, Ch. 46

in high blood pressure: Sec. 3, Ch. 43; Sec. 3, Ch. 43

Angiotensin-converting enzyme (ACE) inhibitors

in aortic regurgitation: Sec. 3, Ch. 48

in coronary artery disease: Sec. 3, Ch. 45

in diabetes: Sec. 3, Ch. 34

fainting with: Sec. 3, Ch. 20

after heart attack: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46

in heart valve disorders: Sec. 3, Ch. 48

in high blood pressure: Sec. 3, Ch. 43; Sec. 3, Ch. 43

high potassium levels with: Sec. 3, Ch. 18

urinary incontinence with: Sec. 3, Ch. 57

Anistreplase: Sec. 3, Ch. 45

Ankle brace: Sec. 2, Ch. 13; Sec. 2, Ch. 13

Antacids

side effects of: Sec. 2, Ch. 6

Anti-interleukin-1 receptor antagonists: Sec. 3, Ch. 41

Antianxiety drugs: Sec. 3, Ch. 32

in shortness of breath: Sec. 2, Ch. 16

Antiarrhythmic drugs: Sec. 3, Ch. 47

intravenous: Sec. 3, Ch. 47

in ventricular tachycardia: Sec. 3, Ch. 47

Antibiotics

in atrophic rhinitis: Sec. 3, Ch. 38

in COPD: Sec. 3, Ch. 53

dizziness with: Sec. 3, Ch. 20

esophageal damage with: Sec. 3, Ch. 54

in pneumonia: Sec. 3, Ch. 52

in prostatitis: Sec. 3, Ch. 59

in rosacea: Sec. 3, Ch. 35

in sinusitis: Sec. 3, Ch. 38

in urinary tract infection: Sec. 3, Ch. 56

in venous ulcers: Sec. 3, Ch. 35

Antibodies

in antiphospholipid syndrome: Sec. 3, Ch. 49

in idiopathic thrombocytopenic purpura: Sec. 3, Ch. 49; Sec. 3, Ch. 49

in multiple myeloma: Sec. 3, Ch. 51

in rheumatoid arthritis: Sec. 3, Ch. 41

Anticardiolipin antibodies: Sec. 3, Ch. 49

Anticholinergic effects: Sec. 2, Ch. 6; Sec. 2, Ch. 6; Sec. 2, Ch. 12

Anticoagulants: Sec. 3 Ch. 49 [sidebar]

in atrial flutter and fibrillation: Sec. 3, Ch. 47

in clotting factor disorders: Sec. 3, Ch. 49

in coronary artery disease: Sec. 3, Ch. 45

in deep vein thrombosis: Sec. 3, Ch. 44

after heart attack: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46; Sec. 3, Ch. 46

in heart valve disorders: Sec. 3, Ch. 48

platelet count and: Sec. 3, Ch. 49

in retinal embolism: Sec. 3, Ch. 36

in stroke prevention: Sec. 3, Ch. 27; Sec. 3, Ch. 28

Anticoagulants

discontinuation of

     before colonoscopy: Sec. 2, Ch. 10

     before electromyography: Sec. 2, Ch. 10

     before esophagogastroduodenoscopy: Sec. 2, Ch. 10

     before prostatic biopsy: Sec. 2, Ch. 10

     before skin biopsy: Sec. 2, Ch. 10

medicinal herb interactions with: Sec. 2, Ch. 7; Sec. 2, Ch. 7

Anticonvulsants

in dementia: Sec. 3, Ch. 27

medicinal herb interactions with: Sec. 2, Ch. 7

in tremor: Sec. 3, Ch. 30

in trigeminal neuralgia: Sec. 3, Ch. 29

urinary incontinence with: Sec. 3, Ch. 57

vitamin D deficiency and: Sec. 3, Ch. 18

Anticytokines: Sec. 3, Ch. 41; Sec. 3, Ch. 41

Antidepressants: Sec. 3, Ch. 32

in anxiety: Sec. 3, Ch. 32

delirium with: Sec. 3, Ch. 26

dizziness with: Sec. 3, Ch. 20

end-of-life care and: Sec. 2, Ch. 6

fainting with: Sec. 3, Ch. 20

in insomnia: Sec. 3, Ch. 31

movement disorder with: Sec. 3, Ch. 30

undernutrition and: Sec. 3 Ch. 17 [detail]; Sec. 3 Ch. 17 [detail]

weight gain with: Sec. 3, Ch. 17

Antidiabetic drugs: Sec. 3, Ch. 34; Sec. 3, Ch. 34

medicinal herb interactions with: Sec. 2, Ch. 7

Antidiuretic hormone

excess of

     low sodium level and: Sec. 3, Ch. 18

     overhydration with: Sec. 3, Ch. 18; Sec. 3, Ch. 18

Antihistamines: Sec. 2, Ch. 6

in allergic rhinitis: Sec. 3, Ch. 38

dizziness with: Sec. 3, Ch. 20; Sec. 3, Ch. 20

in insomnia: Sec. 3, Ch. 31

platelet function and: Sec. 3, Ch. 49

in polycythemia: Sec. 3, Ch. 49

side effects of: Sec. 2, Ch. 6

urinary incontinence with: Sec. 3, Ch. 57

in vasomotor rhinitis: Sec. 3, Ch. 38

Antihyperglycemic drugs: Sec. 3, Ch. 34; Sec. 3, Ch. 34

medicinal herb interactions with: Sec. 2, Ch. 7

Antihypertensive drugs: Sec. 3, Ch. 43

dizziness with: Sec. 3, Ch. 20

in heart valve disorders: Sec. 3, Ch. 48

Antiphospholipid syndrome: Sec. 3, Ch. 49

Antiplatelet drugs: Sec. 3 Ch. 49 [sidebar]

in clotting disorders: Sec. 3, Ch. 49

in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45

after heart attack: Sec. 3, Ch. 45

medicinal herb interactions with: Sec. 2, Ch. 7

in peripheral arterial disease: Sec. 3, Ch. 44

in stroke prevention: Sec. 3, Ch. 28

Antipsychotic drugs: Sec. 2, Ch. 6; Sec. 3, Ch. 32

in delirium: Sec. 3, Ch. 26

in dementia: Sec. 3, Ch. 27

dizziness with: Sec. 3, Ch. 20

movement disorder with: Sec. 3, Ch. 30

swallowing difficulty with: Sec. 3, Ch. 54

undernutrition and: Sec. 3 Ch. 17 [detail]

urinary incontinence with: Sec. 3, Ch. 57

Antispasmodic drugs: Sec. 2, Ch. 6

Antithrombin III deficiency: Sec. 3, Ch. 49

Antiviral drugs

in influenza: Sec. 3, Ch. 52; Sec. 3, Ch. 52

in Parkinson's disease: Sec. 3, Ch. 30; Sec. 3, Ch. 30

Anus

inflammation of: Sec. 2, Ch. 16

in constipation: Sec. 3, Ch. 55

Anxiety: Sec. 3, Ch. 32; Sec. 1, Ch. 1

in dementia: Sec. 3, Ch. 27; Sec. 3 Ch. 32 [sidebar]

drug treatment of: (see Antianxiety drugs)

after heart attack: Sec. 3, Ch. 45

after loved one's death: Sec. 2, Ch. 6

at end of life: Sec. 2, Ch. 16

undernutrition and: Sec. 3 Ch. 17 [detail]; Sec. 3, Ch. 17

Aorta: Sec. 3, Ch. 44; Sec. 3, Ch. 44

aneurysm of: Sec. 3, Ch. 44

     rupture of: Sec. 3, Ch. 44

     in temporal arteritis: Sec. 3, Ch. 42; Sec. 3, Ch. 42; Sec. 3, Ch. 42

dissection of: Sec. 3, Ch. 44

Aortic valve: Sec. 3, Ch. 45; Sec. 3, Ch. 48

bicuspid: Sec. 3, Ch. 48

narrowing (stenosis) of: Sec. 3, Ch. 48

     heart failure and: Sec. 3 Ch. 46 [detail]

regurgitation of: Sec. 3, Ch. 48

thickening (sclerosis) of: Sec. 3, Ch. 48

Aphasia

rehabilitation for: Sec. 2, Ch. 13

in stroke: Sec. 3, Ch. 28

Aphthous stomatitis: Sec. 3, Ch. 39

Aplastic anemia: Sec. 3, Ch. 49; Sec. 3 Ch. 49 [sidebar]

Apolipoprotein E (apo E): Sec. 3 Ch. 27 [detail]

Apoptosis: Sec. 1, Ch. 1

Appetite

drug stimulation of: Sec. 3, Ch. 17

loss of

     at end of life: Sec. 2, Ch. 16

Apraxia: Sec. 2, Ch. 13

Arch pain: Sec. 3, Ch. 40

Arcus senilis: Sec. 1, Ch. 2

Argatroban: Sec. 3 Ch. 49 [sidebar]

Aripiprazole: Sec. 3, Ch. 32

Arm fracture: Sec. 3, Ch. 23

Aromatase inhibitors: Sec. 3, Ch. 51

Arrhythmias: Sec. 3, Ch. 47

atrial fibrillation: Sec. 3, Ch. 49

dizziness with: Sec. 3, Ch. 20

drug-related: Sec. 3, Ch. 47

emergency treatment of: Sec. 3, Ch. 47

fainting with: Sec. 3, Ch. 20; Sec. 3 Ch. 20 [sidebar]

after heart attack: Sec. 3, Ch. 45

heart block: Sec. 3, Ch. 47

in heart valve disorders: Sec. 3, Ch. 48

with high potassium levels: Sec. 3, Ch. 18

in hyperthyroidism: Sec. 3, Ch. 33

outlook for: Sec. 3, Ch. 47

premature beats: Sec. 3, Ch. 47

treatment of: Sec. 3, Ch. 47

ventricular fibrillation: Sec. 3, Ch. 47; Sec. 3, Ch. 47

ventricular tachycardia: Sec. 3, Ch. 47

Arteries: Sec. 3, Ch. 44

aging of: Sec. 1, Ch. 2

aneurysm of: Sec. 3, Ch. 44

collateral: Sec. 3, Ch. 44

dilation of: Sec. 3, Ch. 44

hardening of: Sec. 3, Ch. 44 (see also Atherosclerosis)

in high blood pressure: Sec. 3, Ch. 43

in temporal (giant cell) arteritis: Sec. 3, Ch. 42

Arteriography: (see Angiography)

Arteriovenous malformation: Sec. 3 Ch. 28 [detail]

Arteritis

dizziness with: Sec. 3, Ch. 20

exercise in: Sec. 3, Ch. 60

with hip fracture: Sec. 3, Ch. 23

rheumatoid

     undernutrition and: Sec. 3 Ch. 17 [detail]

temporal: Sec. 3, Ch. 36; Sec. 3, Ch. 36; Sec. 3, Ch. 42

     blood clots with: Sec. 3, Ch. 49

Arthritis

chondroitin in: Sec. 2, Ch. 7

degenerative (osteoarthritis): Sec. 3, Ch. 41

glucosamine in: Sec. 2, Ch. 7

in gout: Sec. 3, Ch. 41

infectious (septic): Sec. 3, Ch. 41

     with pressure sores: Sec. 3, Ch. 35

information resources on: 882

in obesity: Sec. 3, Ch. 17

rheumatoid: Sec. 3, Ch. 41

Arthroplasty (joint replacement)

hip: Sec. 3, Ch. 23

     in osteoarthritis: Sec. 3, Ch. 41

     rehabilitation after: Sec. 2, Ch. 13

     in rheumatoid arthritis: Sec. 3, Ch. 41

knee: Sec. 3, Ch. 41

     in osteoarthritis: Sec. 3, Ch. 41

     rehabilitation after: Sec. 2, Ch. 13

     in rheumatoid arthritis: Sec. 3, Ch. 41

Arthroscopy: Sec. 2, Ch. 10

Artificial leg: Sec. 2, Ch. 13

Ascorbic acid: (see Vitamin C [ascorbic acid])

Aspiration (needle)

in gout: Sec. 3, Ch. 41

in infectious arthritis: Sec. 3, Ch. 41

in pseudogout: Sec. 3, Ch. 41

Aspiration pneumonia: Sec. 3, Ch. 52

with swallowing disorders: Sec. 3, Ch. 54

with tube feeding: Sec. 3, Ch. 17

Aspiration

after esophagogastroduodenoscopy: Sec. 2, Ch. 10

in gastroesophageal reflux: Sec. 3, Ch. 54

with swallowing disorders: Sec. 3, Ch. 54

Aspirin

alcohol interactions with: Sec. 3 Ch. 32 [sidebar]

in clotting disorders: Sec. 3, Ch. 49

in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45

discontinuation of

     before colonoscopy: Sec. 2, Ch. 10

     before electromyography: Sec. 2, Ch. 10

     before esophagogastroduodenoscopy: Sec. 2, Ch. 10

     before prostatic biopsy: Sec. 2, Ch. 10

     before skin biopsy: Sec. 2, Ch. 10

dizziness with: Sec. 3, Ch. 20

for emergency angina treatment: Sec. 3, Ch. 45

esophageal damage with: Sec. 3, Ch. 54

gout drug interaction with: Sec. 3, Ch. 41

after heart attack: Sec. 3, Ch. 45

medicinal herb interactions with: Sec. 2, Ch. 7

for pain: Sec. 3, Ch. 24

in peripheral arterial disease: Sec. 3, Ch. 44

platelet function and: Sec. 3, Ch. 49

in polycythemia: Sec. 3, Ch. 49

in rheumatoid arthritis: Sec. 3, Ch. 41

side effects of: Sec. 2, Ch. 6

in stroke prevention: Sec. 3, Ch. 28

in thrombocythemia: Sec. 3, Ch. 49

Assisted living community: Sec. 2, Ch. 14; Sec. 2, Ch. 14

in dementia: Sec. 3, Ch. 27

overnight care in: Sec. 2, Ch. 15

Assisted suicide: Sec. 2, Ch. 16

Assistive devices: Sec. 2, Ch. 13; Sec. 2, Ch. 13; Sec. 2, Ch. 15

in osteoarthritis: Sec. 3, Ch. 41

in rheumatoid arthritis: Sec. 3, Ch. 41

for walking: Sec. 2, Ch. 13; Sec. 2, Ch. 13

Asteatotic eczema: Sec. 3, Ch. 35

Asterixis (flapping tremor): Sec. 3, Ch. 30

Asthma

ginkgo biloba in: Sec. 2, Ch. 7

Asymptomatic bacteriuria: Sec. 3, Ch. 56

Atenolol

in abnormal heart rhythms: Sec. 3, Ch. 47

in coronary artery disease: Sec. 3, Ch. 45

in heart failure: Sec. 3, Ch. 46

in high blood pressure: Sec. 3, Ch. 43

Atherosclerosis: Sec. 3, Ch. 44; Sec. 3, Ch. 49

in Alzheimer's disease: Sec. 3, Ch. 27

aneurysm and: Sec. 3, Ch. 44

of coronary arteries: Sec. 3, Ch. 45 (see also Coronary artery disease)

in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34

dizziness and: Sec. 3, Ch. 20

erectile dysfunction and: Sec. 3 Ch. 59 [detail]

garlic and: Sec. 2, Ch. 7

information resources on: 884

risk factors for: Sec. 3, Ch. 44

stroke and: Sec. 3 Ch. 28 [detail]; Sec. 3, Ch. 28

treatment of: Sec. 3, Ch. 44

Atorvastatin: Sec. 3, Ch. 44

in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45

Atrial fibrillation: Sec. 3, Ch. 47

blood clots with: Sec. 3, Ch. 49

in heart valve disorders: Sec. 3, Ch. 48; Sec. 3, Ch. 48

in mitral stenosis: Sec. 3, Ch. 48

stroke in: Sec. 3, Ch. 47

Atrial flutter: Sec. 3, Ch. 47

Atrium (atria): Sec. 3, Ch. 45; Sec. 3, Ch. 46

Atrophic rhinitis: Sec. 3, Ch. 38

Atrophic vaginitis: Sec. 1, Ch. 2; Sec. 3, Ch. 58

Atrophy

muscle

     electrical stimulation for: Sec. 2, Ch. 13

nasal: Sec. 3, Ch. 38

urethral: Sec. 3, Ch. 57; Sec. 3, Ch. 57

vocal cord: Sec. 3, Ch. 38

Atropine: Sec. 3, Ch. 47

Attitude

toward aging: Sec. 1, Ch. 1

Audiologist: Sec. 2 Ch. 09 [sidebar]

Audiometry: Sec. 3, Ch. 37

Autoimmune disorders: Sec. 1, Ch. 2

aplastic anemia and: Sec. 3 Ch. 49 [sidebar]

hemolytic anemia and: Sec. 3, Ch. 49

Automated external defibrillator: Sec. 3, Ch. 47

Automobiles

accidents in: Sec. 4, Ch. 62

Autonomy: Sec. 4, Ch. 65

Autumn-winter depression: Sec. 3, Ch. 32

Azathioprine: Sec. 3, Ch. 41

Azelastine: Sec. 3, Ch. 38